Abstract
Introduction As part of infection control measures for COVID-19, individuals have been encouraged to adopt both preventive (e.g., handwashing) and avoidant behavioural changes (e.g., avoiding crowds). In this study, we examined whether demographics predicted the likelihood that a person would adopt these behaviours in Singapore.
Materials and Methods 1145 participants responded to an online survey conducted between 7 March - 21 April 2020. As part of the survey, we collected demographic information and asked participants to report which of 17 behaviour changes they had undertaken because of the outbreak. We ran regression models to predict, using demographic information: (1) the total number of behavioural changes undertaken, (2) the number of preventive changes undertaken, and (3) the number of avoidant changes undertaken. Finally, we sought to identify predictors of persons who: (4) declared that they had not undertaken any of these measures following the outbreak.
Results Females and those who were younger adopted more preventive behaviours: whereas females were more likely to increase handwashing frequency, younger individuals were more likely to wear face masks prior to legislation. Females and those who were married adopted more avoidant behaviours, with both groups avoiding crowded areas and staying home more than usual. Females also voluntarily reduced physical contact, whereas those who were married chose outdoor venues and relied on online shopping.
Conclusion Our characterisation of behavioural changes provides a baseline for public health advisories. Moving forward, local health authorities can focus their efforts to encourage segments of the population who do not readily adopt infection control measures against COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by a grant awarded to the corresponding author from the JY Pillay Global Asia Programme (grant number: IG20-SG002).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Yale-NUS College Ethics Review Committee (#2020-CERC-001), and participants gave written consent in accordance with the Declaration of Helsinki.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.